Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-04

Clinical Trial Update: Efficacy and Safety of Luspatercept: a Study by Fondazione Italiana Sindromi Mielodisplastiche

View source ↗

Summary

A completed clinical trial evaluating the efficacy and safety of luspatercept in myelodysplastic syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Luspatercept (luspatercept)

Snippet

Sponsor: Fondazione Italiana Sindromi Mielodisplastiche-ETS | Conditions: Myeloid Dysplasia | Status: COMPLETED